How to Learn Protein Tyrosine Sulfation: From PAPS and SLC35B2 to TPST1/TPST2, Golgi Modification and Extracellular Recognition

Quick Read. Protein tyrosine sulfation is a post-translational modification that adds sulfate to selected tyrosine residues of secreted and membrane proteins as they pass through the trans-Golgi network. The sulfate donor is PAPS, the Golgi transporter SLC35B2 supplies luminal PAPS, and the enzymes TPST1 and TPST2 install the modification. Sulfotyrosine can strengthen extracellular protein–protein recognition in chemokine receptors, adhesion molecules, coagulation proteins, hormones and other systems.

One-sentence answer: learn tyrosine sulfation as a secretory-pathway recognition system — make PAPS → move PAPS into the Golgi lumen → let TPST1/TPST2 recognise an exposed acidic peptide region → sulfate tyrosine → test how the added negative charge changes extracellular binding.

Wait, what? Two tyrosines can look identical in a sequence but behave differently outside the cell

A tyrosine residue does not stop being chemically interesting once a protein has been translated. If the protein enters the secretory pathway, selected tyrosines can be modified in the Golgi by addition of sulfate. The result is sulfotyrosine, a strongly negatively charged residue that can reshape how a protein binds another protein.

This is a powerful learning example because the modification is not mainly about changing the protein’s interior. It is often about changing the surface language used for extracellular recognition.

Stage 1 — Beginner: sulfate is not phosphorylation

Tyrosine can be modified in several ways. Two students often confuse tyrosine sulfation with tyrosine phosphorylation because both add a negatively charged oxyanion-containing group. They are chemically and biologically different.

• Tyrosine phosphorylation is usually installed by protein kinases, commonly in the cytosol or on cytosolic domains, and is central to intracellular signalling.
• Tyrosine sulfation is installed by tyrosylprotein sulfotransferases in the Golgi lumen and therefore mainly affects secreted proteins or luminal/extracellular portions of membrane proteins.

The compartment tells you which chemistry is even possible. That is the first major connection: cell biology constrains biochemistry.

Stage 2 — Where the sulfate comes from

The sulfate donor is 3′-phosphoadenosine-5′-phosphosulfate, usually abbreviated PAPS. PAPS is an activated sulfate donor used by many sulfotransferases. For protein tyrosine sulfation, the relevant reaction occurs inside the Golgi lumen, so PAPS must be available on the correct side of the membrane.

The nucleotide-sugar-family transporter SLC35B2 is an important PAPS transporter that moves PAPS into the Golgi lumen. This creates a useful systems chain:

cytosolic sulfate activation → PAPS production → Golgi PAPS transport → TPST catalysis → sulfated extracellular protein

If any link fails, downstream sulfation can fall even when the protein substrate and TPST enzyme are present.

Stage 3 — TPST1 and TPST2 read flexible peptide neighbourhoods

Humans have two established tyrosylprotein sulfotransferases, TPST1 and TPST2. They are type II membrane proteins of the trans-Golgi network with catalytic domains facing the lumen. They transfer sulfate from PAPS to the hydroxyl group of tyrosine.

Substrate recognition is not governed by one universal five-letter motif. Acidic residues near the target tyrosine often favour recognition, and structural work shows that substrate peptides occupy an extended binding groove. Flexible or intrinsically disordered regions can be especially suitable because the target tyrosine must physically enter the enzyme’s active-site cleft.

This is why prediction is difficult. A sequence may look “sulfatable” but be inaccessible in the folded protein or never encounter TPST in the correct compartment.

Why sulfotyrosine changes binding

The sulfate group adds negative charge and new hydrogen-bonding and electrostatic possibilities. At a binding interface, that can raise affinity or change specificity. The modification is particularly useful where one extracellular protein must recognise another with high selectivity.

Classic examples include the N-terminal region of the chemokine receptor CCR5 and the adhesion molecule PSGL-1. Sulfated tyrosines in CCR5 contribute to recognition by HIV-1 gp120 during coreceptor engagement. Sulfation of PSGL-1 supports high-affinity interaction with P-selectin and therefore efficient leukocyte rolling.

The lesson is not “sulfation causes HIV infection” or “sulfation causes inflammation.” The correct model is that sulfation tunes molecular recognition within larger biological systems.

Connect the topic to membrane traffic

A protein cannot be tyrosine-sulfated by Golgi TPSTs if it never enters the secretory pathway. This makes protein traffic part of the causal chain. Compare this topic with COPII vesicle budding and ER export. COPII handles movement from ER toward Golgi; tyrosine sulfation is one of the chemical processing events that can occur later as cargo traverses the Golgi system.

A useful transfer question is therefore: if a mutation traps a receptor in the ER, what happens to a sulfated extracellular N-terminus? The answer may be “sulfation falls,” not because TPST is defective, but because substrate and enzyme no longer meet.

Professional level — distinguish pathway capacity from site occupancy

At professional level, avoid treating sulfation as an on/off property of an entire protein. One protein can contain several candidate tyrosines, and different sites can have different occupancy. TPST1 and TPST2 may show overlapping but non-identical preferences. Sulfation can also be incomplete, tissue-dependent and sensitive to PAPS supply and traffic through the Golgi.

This creates at least four separate questions:

• Can the sequence be sulfated?
• Is the protein exposed to TPST in vivo?
• Which tyrosine is actually modified and at what fraction?
• Does that modification measurably alter binding or physiology?

How scientists know

• Enzyme assays test transfer of sulfate from PAPS to candidate peptides.
• Structural biology reveals how TPST recognises PAPS/PAP and substrate peptides.
• Mutagenesis replaces target tyrosines to test site dependence.
• Genetics removes TPST1/TPST2 or PAPS transport to test pathway dependence.
• Binding assays compare sulfated and unsulfated forms of the same ligand or receptor.
• Mass spectrometry can identify sulfotyrosine, although the sulfate ester is chemically labile and technically challenging.
• Animal models reveal physiological consequences that cannot be inferred from peptide binding alone.

Mass spectrometry deserves special caution. Sulfotyrosine can lose sulfate during ionisation or fragmentation. A negative mass-spectrometry result therefore has to be interpreted with method sensitivity in mind. Modern workflows use tailored fragmentation and enrichment strategies to improve confidence.

Current evidence and freshness check

Sources were checked through September 2026. Structural work remains active: a 2026 Scientific Reports study examined metal binding in human TPST2, extending the physical picture of the enzyme. Recent 2026 work has also continued to reveal functional consequences of site-specific sulfotyrosine, including a study in which sulfation of the thrombin-binding protein triabin enhanced inhibition through multiple interaction modes. A May 2026 preprint reported a sulfotyrosine motif in the extracellular domain of TrkB that may contribute to agonist activation. Because that TrkB report is a preprint, it should be treated as emerging evidence rather than settled textbook fact.

Misconceptions to remove

• “Tyrosine sulfation is another name for phosphorylation.” False.
• “Any tyrosine near acidic residues will be sulfated.” False. Compartment, structure and enzyme access matter.
• “TPST acts in the cytosol.” False. Its catalytic domain acts in the Golgi lumen.
• “Sulfation always switches a protein on.” False. It can strengthen, weaken or alter recognition depending on the binding partner.
• “One protein has one sulfation state.” Too simple. Multiple sites and partial occupancy are common possibilities.

Model limits

A textbook arrow from TPST to “sulfated protein” hides supply, transport and geometry. PAPS concentration can limit reaction capacity. SLC35B2 and related transport processes determine luminal donor availability. Golgi residence time affects enzyme encounter. Local peptide conformation determines whether the tyrosine can enter the catalytic cleft. The extracellular consequence then depends on the partner that meets the modified surface.

The safest professional model is therefore:

modification potential ≠ modification occupancy ≠ binding consequence ≠ organism-level phenotype

Transfer checks

• A secreted protein contains an excellent acidic sulfation motif but is not sulfated. Give four possible explanations.
• A mutation in SLC35B2 reduces sulfation of many proteins. Why does this not prove SLC35B2 is a sulfotransferase?
• Two receptors carry the same number of sulfotyrosines but show different ligand affinity. What else could differ?
• How would you distinguish loss of sulfation from loss of receptor surface expression?
• Why can a peptide experiment overestimate what happens in a folded full-length protein?

Beginner-to-professional learning route

Beginner: know that sulfate can be attached to tyrosine. Intermediate: add Golgi location, PAPS, SLC35B2 and TPST1/TPST2. Advanced: study substrate recognition, extracellular binding and technical detection. Professional: reason about occupancy, Golgi traffic, donor supply, isoform specificity, assay bias and causal physiology.

Evidence sources for further study

• Crystal structure of human TPST2 and the mechanism of protein tyrosine sulfation
• Structural basis for the broad substrate specificity of human TPST1
• Structural characterization of metal binding in human TPST2 (2026)
• Tyrosine sulfation of PSGL-1 and leukocyte rolling
• Tyrosine-sulfated peptides and HIV-1 coreceptor mimicry

Tyrosine sulfation is a compact example of how cells combine chemistry with logistics. The enzyme matters, but so do the donor, the membrane transporter, the cargo route, the three-dimensional site and the extracellular partner. Learn the whole chain and the topic becomes far easier to transfer.